Explore federal awards
Date filters select awards with transaction activity in the period. Amounts below are lifetime award obligations. IDV values remain separate.
Export these results to CSV · 15 matching records
PROCUREMENT OF INTRAVENOUS STABLE ISOTOPE (POTASSIUM PALMITATE U-13C) FOR METABOLIC RESEARCHDepartment of Health and Human Services$41.5K obligationsEnds Aug 20, 2027
NIDDK: STABLE ISOTOPES DEUTERIUM OXIDE (D, 70%), GLYCEROL (D5 GLYCEROL), AND GLUCOSE (6,6 DEUTERATED GLUCOSE)Department of Health and Human Services$410.8K obligationsEnds Sep 30, 2026
NIDDK METABOLIC ISOTOPESDepartment of Health and Human Services$54.5K obligationsEnds Sep 29, 2029
503B COMPOUNDING PHARMACEUTICALSDepartment of Veterans Affairs$21.7K obligationsEnds Mar 31, 2026
1. 26-003399 - IDIQ 75N94024D00003, SEND PO TO AGENTILE@PINEPHARMACEUTICALS.COM, DELIVERY BY 6/1/26; ORAL STABLE ISOTOPE-DEUTERIUM OXIDE, BILLING IN ONE LUMP SUM, NIH POC…Department of Health and Human Services$39.3K obligationsEnds Oct 30, 2026
STORAGE AND STABILITY TESTING BY PINE PHARMACEUTICALS, LLC:1270808 [POTS: 20-011114]Department of Health and Human Services$0 obligationsEnds Sep 8, 2021
ATORVASTATIN 40 MG CAPSULES AND PLACEBO CAPSULES, QTY 1,232 BATCH.Department of Health and Human Services$24.7K obligationsEnds Feb 16, 2027
503B COMPOUNDING PHARMACEUTICALSDepartment of Veterans Affairs$37.7K obligationsEnds Sep 30, 2025
NIDDK: SERVICE: INTRAVENOUS STABLE ISOTOPE GLUCOSE (6,6 DEUTERATED GLUCOSE) FOR METABOLIC RESEARCH. NONSEVERABLEDepartment of Health and Human Services$69.5K obligationsEnds May 31, 2026
NIDDK: PROCUREMENT OF INTRAVENOUS STABLE ISOTOPE GLUCOSE (6,6 DEUTERATED GLUCOSE) FOR METABOLIC RESEARCH. NONSEVERABLE.Department of Health and Human Services$91.9K obligationsEnds May 31, 2026
NIDDK: SERVICE: INTRAVENOUS STABLE ISOTOPE GLUCOSE (D5 GLYCEROL) FOR METABOLIC RESEARCH.Department of Health and Human Services$81.7K obligationsEnds Apr 30, 2026
PINE PHARMACEUTICALS, LLC:1270808 [25-001246] THE CURRENT TRIAL RELIES ON UNIFORMITY OF DRUG FORMULATION, EXCIPIENT COMPOSITION, APPEARANCE, AND PACKAGING THROUGHOUT THE STUDY…Department of Health and Human Services$122.0K obligationsEnds Jan 31, 2026
COMPOUNDING OF 10% POLYSORBATE-80 TO DILUTE TPM-001 INVESTIGATIONAL DRUG FOR TREATMENT OF PERITONEAL CANCERDepartment of Health and Human Services$23.8K obligationsEnds May 2, 2025
NIDDK: SERVICE: METABOLIC ISOTOPES: NON-SEVERABLEDepartment of Health and Human Services$158.9K obligationsEnds Apr 13, 2026
503B COMPOUNDING PHARMACEUTICALSDepartment of Veterans Affairs$37.1K obligationsEnds Sep 30, 2024